Substance Abuse Prevention

Smart Approaches to Marijuana Impact Report 2026-2027: Lessons Learned from State Marijuana Legalization

egowan — Tue, 13 Jan 2026 16:20:16 +0000

Smart Approaches to Marijuana Impact Report 2026-2027: Lessons Learned from State Marijuana Legalization egowan Tue, 01/13/2026 - 11:20

The SAM Impact Report 2026-2027 presents research and data to evaluate the public health and safety impacts of marijuana legalization and commercialization. The report highlights associations between increased marijuana availability and usage rates, emergency medical events, impaired driving, and challenges in youth prevention. It concludes with policy-focused recommendations.

Data Categories:

Substance Abuse Prevention

Report

2026

Topics:

marijuana

Smart Approaches to Marijuana. (2026). SAM impact report 2026-2027: Lessons learned from state marijuana legalization [PDF]. https://learnaboutsam.org/wp-content/uploads/2026/01/SAM-impact-report-2026-2027.pdf

Georgia Social Indicator Study - 2025

egowan — Mon, 15 Dec 2025 14:16:03 +0000

Georgia Social Indicator Study - 2025 egowan Mon, 12/15/2025 - 09:16

The Georgia Social Indicator Study examines social indicators in conjunction with substance use in Georgia on a county-level to produce a predictive analysis regarding the association between social indicators and substance use. Volumes I, II, & III cover all substance use indicators. Volumes IV, V, & VI focus on opioid-specific indicators. This study will serve as a timely and useful tool in prevention planning.

Volume I. Georgia's 2025 County-Level Study to Assess Substance Use and Related Consequences

Volume II. County-by-County Prevention Needs Assessment Profiles

Volume III. County-Level Prevalence Tables

Volume IV. Georgia's 2025 County-Level Study to Assess Substance Use and Related Consequences (Opioids)

Volume V. County-by-County Prevention Needs Assessment Profiles (Opioids)

Volume VI. County-Level Prevalence Tables (Opioids)

Data Categories:

Substance Abuse Prevention Suicide Prevention

Epidemiological Profile

2025

Topics:

alcohol tobacco heroin methamphetamines cocaine suicide prescription drugs e-cigarette/vape opioids marijuana epi profile

Georgia Social Indicator Study

Georgia Department of Behavioral Health and Developmental Disabilities & RTI International. (2025). Georgia's 2025 County-Level Social Indicator Study to Assess Substance Use and Related Consequences: Volume I. https://gaspsdata.dbhdd.ga.gov/data/georgia-social-indicator-study-2025

Georgia Department of Behavioral Health and Developmental Disabilities & RTI International. (2025). Georgia Social Indicator Study: Volume II. County-by-County Prevention Needs Assessment Profiles. https://gaspsdata.dbhdd.ga.gov/data/georgia-social-indicator-study-2025

Georgia Department of Behavioral Health and Developmental Disabilities & RTI International. (2025). Georgia Social Indicator Study: Volume III. County-Level Prevalence Tables. https://gaspsdata.dbhdd.ga.gov/data/georgia-social-indicator-study-2025

Georgia Department of Behavioral Health and Developmental Disabilities & RTI International. (2025). Georgia's County-Level Social Indicator Study to Assess Substance Use and Related Consequences: Opioids - Volume IV. https://gaspsdata.dbhdd.ga.gov/data/georgia-social-indicator-study-2025

Georgia Department of Behavioral Health and Developmental Disabilities & RTI International. (2025). Georgia Social Indicator Study - Opioids: Volume V. County-by-County Prevention Needs Assessment Profiles. https://gaspsdata.dbhdd.ga.gov/data/georgia-social-indicator-study-2025

Georgia Department of Behavioral Health and Developmental Disabilities & RTI International. (2025).Georgia Social Indicator Study - Opioids: Volume VI. County-Level Prevalence Tables. https://gaspsdata.dbhdd.ga.gov/data/georgia-social-indicator-study-2025

Tobacco Product Use Among Middle and High School Students — National Youth Tobacco Survey, United States, 2024

egowan — Thu, 02 Jan 2025 20:48:57 +0000

Tobacco Product Use Among Middle and High School Students — National Youth Tobacco Survey, United States, 2024 egowan Thu, 01/02/2025 - 15:48

CDC and the Food and Drug Administration analyzed data from the 2024 National Youth Tobacco Survey to assess tobacco product use patterns among U.S. middle school (grades 6–8) and high school (grades 9–12) students.

From 2023 to 2024, current (previous 30-day) use of any tobacco product declined among high school students from 12.6% to 10.1%, largely driven by the decline in high school e-cigarette use (from 10.0% to 7.8%). During 2024, e-cigarettes remained the most commonly used tobacco product among U.S. youths; nicotine pouches were the second most commonly used tobacco product.

Data Categories:

Substance Abuse Prevention

MMW Report

2024

Topics:

e-cigarette/vape tobacco

Tobacco Product Use Among U.S. Middle and High School Students — National Youth Tobacco Survey, 2023

Tobacco Product Use and Associated Factors Among Middle and High School Students

Tobacco Product Use Among Middle and High School Students

Jamal A, Park-Lee E, Birdsey J, et al. Tobacco Product Use Among Middle and High School Students — National Youth Tobacco Survey, United States, 2024. MMWR Morb Mortal Wkly Rep 2024;73:917–924. DOI: http://dx.doi.org/10.15585/mmwr.mm7341a2

Behavioral Health of Adolescents across Sexual Identities: Results from the 2023 National Survey on Drug Use and Health

egowan — Thu, 02 Jan 2025 20:27:54 +0000

Behavioral Health of Adolescents across Sexual Identities: Results from the 2023 National Survey on Drug Use and Health egowan Thu, 01/02/2025 - 15:27

This report explores behavioral health indicators by sexual identity among adolescents aged 12 to 17 in the United States. Estimates based on 2023 NSDUH data.

Data Categories:

Mental Health Promotion Substance Abuse Prevention Suicide Prevention

National Survey Report

2023

Topics:

alcohol tobacco e-cigarette/vape marijuana cocaine stimulants opioids prescription drugs illicit drugs mental health suicide

Substance Abuse and Mental Health Services Administration. (2024). Behavioral health of adolescents across sexual identities: Results from the 2023 National Survey on Drug Use and Health (SAMHSA Publication No. PEP24-07-028). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/report/lgb-adolescent-behavioral-health-2023

National Substance Use and Mental Health Services Survey (N-SUMHSS), 2023: Data on Substance Use and Mental Health Treatment Facilities

egowan — Thu, 02 Jan 2025 17:08:18 +0000

National Substance Use and Mental Health Services Survey (N-SUMHSS), 2023: Data on Substance Use and Mental Health Treatment Facilities egowan Thu, 01/02/2025 - 12:08

This report presents results from the 2023 National Substance Use and Mental Health Services Survey (N-SUMHSS), an annual survey of substance use and mental health treatment facilities in the United States.

Data Categories:

Mental Health Promotion Substance Abuse Prevention Suicide Prevention

National Survey Report

2023

Topics:

mental health outcomes

National Substance Use and Mental Health Services Survey (N-SUMHSS), 2021: Data on Substance Use and Mental Health Treatment Facilities

National Substance Use and Mental Health Services Survey (N-SUMHSS), 2022: Data on Substance Use and Mental Health Treatment Facilities

Substance Abuse and Mental Health Services Administration. (2023). National Substance Use and Mental Health Services Survey (N-SUMHSS): Data on Substance Use and Mental Health Treatment Facilities. Publication No. PEP24-07- 027 MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, 2024. Retrieved from https://www.samhsa.gov/data/report/2023-n-sumhss-annual-report

National Estimates from Drug-Related Emergency Department Visits, 2023

egowan — Thu, 02 Jan 2025 15:40:37 +0000

National Estimates from Drug-Related Emergency Department Visits, 2023 egowan Thu, 01/02/2025 - 10:40

"In 2023, DAWN identified 138,859 (unweighted) drug-related ED visits from 53 participating hospitals. These data were analyzed to generate nationally representative weighted estimates for (1) all drug-related ED visits, (2) the top substances involved in drug-related ED visits, (3) opioid-related ED visits by type, and (4) polysubstance-related ED visits."

Data Categories:

Substance Abuse Prevention

National Report

2023

Topics:

alcohol opioids marijuana methamphetamines cocaine prescription drugs illicit drugs outcomes

Preliminary Findings from Drug-Related Emergency Department Visits, 2021

Findings from Drug-Related Emergency Department Visits, 2022

Substance Abuse and Mental Health Services Administration. (2024). Drug Abuse Warning Network: National Estimates from Drug-Related Emergency Department Visits, 2023. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data.

Tobacco Product Use Among U.S. Middle and High School Students — National Youth Tobacco Survey, 2023

egowan — Thu, 02 Nov 2023 19:57:12 +0000

Tobacco Product Use Among U.S. Middle and High School Students — National Youth Tobacco Survey, 2023 egowan Thu, 11/02/2023 - 15:57

CDC and the Food and Drug Administration analyzed data from the 2023 National Youth Tobacco Survey to assess tobacco product use patterns among U.S. middle school (grades 6–8) and high school (grades 9–12) students.

From 2022 to 2023, current e-cigarette use among high school students declined from 14.1% to 10.0%. E-cigarettes remained the most commonly used tobacco product among youths.

Data Categories:

Substance Abuse Prevention

MMW Report

2023

Topics:

e-cigarette/vape tobacco

Tobacco Product Use and Associated Factors Among Middle and High School Students

Tobacco Product Use Among Middle and High School Students

Tobacco Product Use Among Middle and High School Students — National Youth Tobacco Survey, United States, 2024

Birdsey J, Cornelius M, Jamal A, et al. (2023). Tobacco Product Use Among U.S. Middle and High School Students — National Youth Tobacco Survey, 2023. Morbidity and Mortality Weekly Report, 72(44):1173–1182. https://www.cdc.gov/mmwr/volumes/72/wr/mm7244a1.htm?s_cid=mm7244a1_w

Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose

egowan — Wed, 17 Jul 2024 19:41:30 +0000

Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose egowan Wed, 07/17/2024 - 15:41

An 8-mg intranasal naloxone formulation, a higher-concentration product than had previously been available, was approved by the Food and Drug Administration (FDA) in 2021 for emergency treatment of known or suspected opioid overdose. This study examined outcomes among persons who received the 8-mg naloxone product and those who receive the usual 4-mg product to treat suspected overdose in New York state. New York State Department of Health (NYSDOH) partnered with New York State Police (NYSP) to field test 8-mg intranasal naloxone use by some NYSP troops.

Despite the increased naloxone concentration in the 8-mg intranasal product, no significant differences were found in the survival of aided persons, or the number of doses administered by law enforcement by formulation, suggesting that, in this field test, the increased dosage did not provide added benefit, even in light of the increased prevalence of synthetic opioids, including fentanyl, in the drug supply.

Data Categories:

Substance Abuse Prevention

MMW Report

2022-2023

Topics:

opioids outcomes

Payne ER, Stancliff S, Rowe K, Christie JA, Dailey MW. Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose — New York, March 2022–August 2023. MMWR Morb Mortal Wkly Rep 2024;73:110–113. DOI: http://dx.doi.org/10.15585/mmwr.mm7305a4

National Substance Use and Mental Health Services Survey (N-SUMHSS), 2022: Data on Substance Use and Mental Health Treatment Facilities

egowan — Thu, 02 Jan 2025 17:04:05 +0000

National Substance Use and Mental Health Services Survey (N-SUMHSS), 2022: Data on Substance Use and Mental Health Treatment Facilities egowan Thu, 01/02/2025 - 12:04

This report presents results from the 2022 National Substance Use and Mental Health Services Survey (N-SUMHSS), an annual survey of substance use and mental health treatment facilities in the United States.

Data Categories:

Mental Health Promotion Substance Abuse Prevention Suicide Prevention

National Survey Report

2022

Topics:

mental health outcomes

National Substance Use and Mental Health Services Survey (N-SUMHSS), 2021: Data on Substance Use and Mental Health Treatment Facilities

National Substance Use and Mental Health Services Survey (N-SUMHSS), 2023: Data on Substance Use and Mental Health Treatment Facilities

Substance Abuse and Mental Health Services Administration. (2023). National Substance Use and Mental Health Services Survey (N-SUMHSS) 2022: Data on Substance Use and Mental Health Treatment Facilities (SAMHSA Publication No. PEP23-07-00-002).Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/.

Findings from Drug-Related Emergency Department Visits, 2022

egowan — Thu, 02 Jan 2025 15:26:26 +0000

Findings from Drug-Related Emergency Department Visits, 2022 egowan Thu, 01/02/2025 - 10:26

"In 2022, the Drug Abuse Warning Network (DAWN) identified 143,596 (unweighted) drug-related emergency department (ED) visits from 53 participating hospitals. These data were analyzed to generate nationally representative weighted estimates (1) for all drug-related ED visits, (2) for the top drugs involved in drug-related ED visits, (3) for different opioid types involved in ED visits, (4) to describe polysubstance in ED visits, and (5) to identify newly mentioned drugs in 2022."

Data Categories:

Substance Abuse Prevention

National Report

2022

Topics:

alcohol opioids marijuana methamphetamines cocaine prescription drugs illicit drugs outcomes

Preliminary Findings from Drug-Related Emergency Department Visits, 2021

National Estimates from Drug-Related Emergency Department Visits, 2023

Substance Abuse and Mental Health Services Administration. (2023). Drug Abuse Warning Network: Findings from Drug-Related Emergency Department Visits, 2022 (HHS Publication No. PEP23-07-03-001). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/.